Chemical Stability of Methadone Concentrate and Powder Diluted in Orange-Flavored Drink
Download in electronic PDF format for $75
Abstract: Methadone, traditionally used in the treatment of heroin addiction, recently has been used to treat severe pain. The chemical stability of methadone has been studied in concentrations up to 1.5 mg/mL only. Commercial methadone concentrate (10 mg/mL) and methadone powder was diluted to 5 mg/mL with orange-flavored Tang drink. Sodium benzoate was added to the solutions prepared from powder. Bottles were stored at either room temperature (22 degrees C) or under refrigeration (6 degrees C) for 91 days. Samples were analyzed in duplicate by a stability-indicating high-performance liquid chromatographic assay, and clarity and pH were also monitored. One additional solution was prepared from powder but no preservative was added; this solution was monitored for presence of bacterial growth at room temperature only. Solutions prepared from the concentrate and powder with preservative showed no signs of change in clarity on storage. The solution made from powder only developed turbidity after 21 days, which suggested bacterial growth. There was no significant change in pH over the course of the study. After 91 days of storage at either room temperature or under refrigeration, there was no change in concentration for solutions prepared from concentrate or powder with preservative. Methadone solutions prepared from the commercial concentrate or powder with sodium benzoate are stable for 91 days at room temperature or under refrigeration. Solutions prepared from the powder but not containing a preservative showed signs of bacterial growth after 21 days at room temperature.
Related Keywords:
Ron Donnelly, MSc (Chem), BSc (Pharm), methadone, pain relief, pain control, preservative
Related Articles from IJPC |
Title/Author
(Click for Abstract / Details / Purchase) |
Issue/Page
View/Buy |
Chemical Stability of Methadone Concentrate and Powder Diluted in Orange-Flavored Drink
Donnelly Ronald F
|
Nov/Dec 2004
Pg. 489-491
|
PostScription: Treatment of Chronic Pain with Methadone or Levorphanol
McNulty Jack P
|
Mar/Apr 2006
Pg. 159-160
|
Featured Excipient: Flavor Enhancing Agents
Allen Loyd V Jr
|
Jan/Feb 2003
Pg. 48-50
|
Compounded Analgesic Therapy for Disorders of Movement: Arthritis, Neuropathic Pain, and Postpolio Syndrome
Brown Scott, Erickson Brian, Muller George, Bryant-Snure Susan J, Mestayer Richard F III
|
May/Jun 2010
Pg. 182-192
|
Topical Medications for Orofacial Neuropathic Pain
Bramwell Bethany L
|
May/Jun 2010
Pg. 200-203
|
Chemical Stability of Fentanyl in Polypropylene Syringes and Polyvinylchloride Bags
Donnelly Ronald F
|
Nov/Dec 2005
Pg. 482-483
|
Oral Methadone for Management of Regional Sympathetic Dystrophy Syndrome: A Case Revisited
Vail Jane
|
May/Jun 2007
Pg. 187-192
|
Compounded Pain Formulations: What is the Evidence?
Asbill Scott, Sweitzer Sarah M, Spigener Shuler, Romero-Sandoval Alfonso
|
Jul/Aug 2014
Pg. 278-286
|
Compounded Pain Formulations: What is the Evidence?
Asbill Scott, Sweitzer Sarah M, Spigener Shuler, Romero-Sandoval Alfonso
|
Mar/Apr 2024
Pg. 100-109
|
Levorphanol, Methadone, and the Management of Intractable Chronic Pain: An Interview with Kerry Schmidt, BA, MBA; Jack P. McNulty, MD, FACP; and George B. Muller, RPh
Vail Jane
|
Jan/Feb 2006
Pg. 9-11
|
Stability of Venlafaxine Immediate-Release Suspensions
Donnelly Ronald F, Wong Keith, Goddard Rob, Johanson Christel
|
Jan/Feb 2011
Pg. 81-84
|
Efficacy and Clinical Value of Commonly Used Ingredients in Pain Management Compounds: A Literature Review
Beshay Sarah M, Rivera Gerard, Balthasar Jan, Florea Naomi
|
Jul/Aug 2015
Pg. 295-300
|
Case Reports: Compounding to Relieve Arthritis Pain
Marshall Robert, Vidaurri Vincent A, Boomsma Diane, Buchta Anthony J, Vail Jane
|
Nov/Dec 2008
Pg. 498-504
|
Update on Managing Neuropathic Pain
McNulty Jack P, Muller George
|
May/Jun 2009
Pg. 182-190
|
Efficacy and Clinical Value of Commonly Used Ingredients in Pain Management Compounds: A Literature Review
Beshay Sarah M, Rivera Gerard, Balthasar Jan, Florea Naomi
|
Mar/Apr 2024
Pg. 111-116
|
Stability Studies of Fludrocortisone Acetate Capsules and Fludrocortisone Acetate Titrated Powders (Powder Triturates)
Brandin Thibaut, Wasilewski Maya, Panuccio Camille, Bouguergour Cyrielle, Primas Nicolas, Lamy Edouard, Jean Christophe, Bertault-Peres Pierre, Rathelot Pascal, Curti Christophe, Vanelle Patrice
|
Mar/Apr 2022
Pg. 150-154
|
Topical Pain Relief: Assessment of Patient Satisfaction with a Novel Compound Containing at Least Ketoprofen
Zugerman Jessie Jean M, Reed Thomas C
|
Nov/Dec 2007
Pg. 514-519
|
Topical Ketamine: A Review of the History, Mechanisms, Uses, Safety, and Future
Rabi Joseph
|
Mar/Apr 2016
Pg. 107-113
|
Stability of Fentanyl Citrate in Polyolefin Bags
Donnelly Ronald F
|
Nov/Dec 2016
Pg. 514-516
|
Levorphanol for the Treatment of Severe Chronic Pain
McNulty Jack P
|
May/Jun 2007
Pg. 202-211
|
Return to Top |